Search Results - "Voskanyan, Astghik"

Management of CML-blast crisis by Hehlmann, Rüdiger, Prof. Dr. med, Saußele, Susanne, PD Dr. med, Voskanyan, Astghik, Dr, Silver, Richard T., Prof

“…Abstract Tyrosine kinase inhibitors (TKI) have moderately improved survival in BC, but a median survival of less than 1 year is still unsatisfactory. This…”
Get full text

Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials by Spiess, Birgit, Rinaldetti, Sébastien, Naumann, Nicole, Galuschek, Norbert, Kossak-Roth, Ute, Wuchter, Patrick, Tarnopolscaia, Irina, Rose, Diana, Voskanyan, Astghik, Fabarius, Alice, Hofmann, Wolf-Karsten, Saußele, Susanne, Seifarth, Wolfgang

“…In chronic myeloid leukemia (CML), the duration of deep molecular response (MR) before treatment cessation (MR4 or deeper, corresponding to BCR-ABL1 ≤ 0.01% on…”
Get full text

Overview of Cancer Control in Armenia and Policy Implications by Bedirian, Karen, Aghabekyan, Tigran, Mesrobian, Arianna, Shekherdimian, Shant, Zohrabyan, Davit, Safaryan, Liana, Sargsyan, Lilit, Avagyan, Armen, Harutyunyan, Lilit, Voskanyan, Astghik, Tadevosyan, Artashes, Melik-Nubaryan, Davit, Khachatryan, Parandzem, Saghatelyan, Tatul, Kostanyan, Mher, Vardevanyan, Hovhannes, Hovhannisyan, Marine, Sarkisian, Tamara, Sargsyan, Karine, Babikyan, Davit, Tananyan, Armen, Danielyan, Samvel, Muradyan, Armen, Tamamyan, Gevorg, Bardakhchyan, Samvel

“…Cancer is the second leading cause of death in Armenia. Over the past two decades, the country has seen a significant rise in cancer morbidity and mortality…”
Get full text

PB2322: MULTIPLE PRIMARY TUMORS IN PATIENTS WITH NON‐HODGKIN’S LYMPHOMA: A RETROSPECTIVE SINGLE‐CENTER STUDY by Sahakyan, Lusine, Harutyunyan, Lusine, Melik‐Andreasyan, Marine, Poghosyan, Alvard, Voskanyan, Astghik, Danelyan, Samvel, Ghazaryan, Narine

Get full text

PB1983: RELATIONSHIP BETWEEN REGULAR MOLECULAR MONITORING AND TREATMENT OUTCOMES IN CML PATIENTS IN ARMENIA by Harutyunyan, Lusine, Ivanyan, Arusyak, Ghazaryan, Narine, Voskanyan, Astghik, Meliksetyan, Karen, Ter‐Grigoryan, Anahit, Aynajyan, Anahit, Khachatryan, Tatev, Hakobyan, Yervand, Oganesyan, Artem

Get full text

Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia by Avagyan, Armen, Danielyan, Samvel, Voskanyan, Astghik, Sargsyan, Lilit, Hakobyan, Lusine, Zohrabyan, Davit, Safaryan, Liana, Harutyunyan, Lilit, Bardakchyan, Samvel, Iskanyan, Samvel, Arakelyan, Samvel, Tamamyan, Gevorg

“…Background: With advances in diagnostics and treatment approaches, patients with Hodgkin's lymphoma (HL) in developed countries can nowadays expect to have…”
Get full text

Why adult patients with acute leukemias are dying in the developing world: The other side of the coin by Voskanyan, Astghik, Ivanyan, Arusyak, Harutyunyan, Lusine, Movsisyan, Alisa, Ghahramanyan, Nerses, Sahakyan, Lusine, Danielyan, Samvel, Tamamyan, Gevorg

“…e19035 Background: Majority of the patients with acute leukemias can reach complete remission (CR) in case of appropriate therapy and many of those in CR are…”
Get full text

Epidemiological Profile of Polycythemia Vera Patients Diagnosed during 2016-2020: An Ethnic Variation in Armenia by Badikyan, Maria, Martirosyan, Nare, Hambardzumyan, Liana, Movsisyan, Alisa, Ivanyan, Arusyak, Melkikyan, Nata, Tamamyan, Gevorg, Kazandjian, Dickran, Voskanyan, Astghik

“…Background: Polycythemia Vera (PV), a rare myeloproliferative neoplasm, exhibits variations in disease characteristics across diverse ethnic populations…”
Get full text

Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting by Khan, Fiza, Hashmi, Foorquan, Ghahramanyan, Nerses, Baloyan, Elen, Tamamyan, Gevorg, Konopleva, Marina, Pemmaraju, Naveen, Voskanyan, Astghik

“…Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematological malignancy with limited treatment options and poor prognosis. This…”
Get more information

Impact of emerging ACA on survival in chronic myeloid leukemia (CML) by Hehlmann, Rüdiger, Lauseker, Michael, Voskanyan, Astghik, Fabarius, Alice, Haferlach, Claudia, Hochhaus, Andreas, Saußele, Susanne

Get full text

Diagnosis and Treatment of Ph+ Acute Lymphoblastic Leukemia in Armenia: A Comprehensive Analysis From 2012 to 2023 by Martirosyan, Nare, Ivanyan, Arusyak, Badikyan, Maria, Harutyunyan, Lusine, Hovhannisyan, Manush, Vanoyan, Araksya, Tamamyan, Gevorg, Voskanyan, Astghik

Get full text

ALL-544 Diagnosis and Treatment of Ph+ Acute Lymphoblastic Leukemia in Armenia: A Comprehensive Analysis From 2012 to 2023 by Martirosyan, Nare, Ivanyan, Arusyak, Badikyan, Maria, Harutyunyan, Lusine, Hovhannisyan, Manush, Vanoyan, Araksya, Tamamyan, Gevorg, Voskanyan, Astghik

“…Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) constitutes a significant portion, approximately 20–30%, of adult ALL cases. Ph+ ALL is aggressive…”
Get full text

MM-225 Complex Clinical Presentation of Late-Stage AL Amyloidosis: A Case Report by Gevorgyan, Manon, Harutyunyan, Lusine, Ghahramanyan, Nerses, Kostanyan, Tigranuhi, Voskanyan, Astghik, Tamamyan, Gevorg, Simonyan, Armine

“…AL amyloidosis (primary amyloidosis) is a rare hematological disorder characterized by the deposition of amyloid fibrils in various organs, leading to…”
Get full text

MM-469 The Prognostic Value of Serum Calcium Levels, Neutrophil to Lymphocyte Ratio and Platelet Count in Multiple Myeloma: A Retrospective Cohort Study by Avagyan, Gevorg, Voskanyan, Astghik, Grigoryan, Hayk, Saaryan, Miranush, Muradyan, Laura, Avagyan, Gevorg, Ghahramanyan, Nerses

“…Multiple myeloma (MM) is a hematological malignancy characterized by the proliferation of monoclonal plasma cells. Numerous prognostic parameters are described…”
Get full text

The Prognostic Value of Serum Calcium Levels, Neutrophil to Lymphocyte Ratio, and Platelet Count in Multiple Myeloma: A Retrospective Cohort Study by Avagyan, Gevorg, Voskanyan, Astghik, Grigoryan, Hayk, Saaryan, Miranush, Muradyan, Laura, Tamamyan, Gevorg, Ghahramanyan, Nerses

Get full text

Complex Clinical Presentation of Late-Stage AL Amyloidosis: A Case Report by Gevorgyan, Manon, Harutyunyan, Lusine, Ghahramanyan, Nerses, Kostanyan, Tigranuhi, Voskanyan, Astghik, Tamamyan, Gevorg, Simonyan, Armine

Get full text

Patterns of unmet needs of adolescents and young adults (AYA) in the developing world: Beyond the walls by Papyan, Ruzanna, Hovsepyan, Shushan, Sargsyan, Lilit, Vagharshakyan, Lala, Voskanyan, Astghik, Bardakhchyan, Samvel, Harutyunyan, Martin, Mosesyan, Iveta, Hakobyan, Lusine, Hoveyan, Julieta, Danielyan, Samvel, Tamamyan, Gevorg

“…e18612 Background: Adolescents and young adults (AYA) with cancer are a special group of patients with unique characteristics. To face the complex clinical,…”
Get full text

POSTER: MPN-505 Diagnostic Challenges of Polycythemia Vera in Low- or Middle-Income Countries: Addressing the Diagnostic Gap by Badikyan, Maria, Tamamyan, Gevorg, Martirosyan, Nare, Hambardzumyan, Liana, Movsisyan, Alisa, Saghumyan, Gevorg, Melkikyan, Nata, Voskanyan, Astghik

Get full text

POSTER: HL-393 5-year Overall Survival Rate of Patients With Classical Hodgkin Lymphoma in Armenia by Evoyan, Levon, Tamamyan, Gevorg, Ivanyan, Arusyak, Ter-Grigoryan, Anahit, Saaryan, Miranush, Danelyan, Samvel, Voskanyan, Astghik

Get full text

HL-393 5-year Overall Survival Rate of Patients With Classical Hodgkin Lymphoma in Armenia by Evoyan, Levon, Tamamyan, Gevorg, Ivanyan, Arusyak, Ter-Grigoryan, Anahit, Saaryan, Miranush, Danelyan, Samvel, Voskanyan, Astghik

“…Hodgkin lymphoma (HL) is one of the most curable malignancies with a 5-year survival of over 80%. Classical HL (cHL) accounts for 95% of all HL and is…”
Get full text